The histopathology of the liver in older patients with hepatitis B virus surface antigenaemia. 1991

H Sugimura, and T Fukazawa, and M Saitoh, and K Nakamura, and H Shimada, and K Ohtsubo
Department of Clinical Pathology, Tokyo Metropolitan Institute of Gerontology, Japan.

The histopathology of the liver and the detectability of intrahepatic hepatitis B virus (HBV) markers were studied in 34 autopsy cases in elderly patients (mean age 73.9 years, range 60-91 years) who had had a history of positive HBV surface antigenaemia prior to death. Seven of 14 persistent HBV carrier cases (group A) in which long-lasting HBV surface antigen (HBsAg) carriage in the sera had been confirmed by sequential assays, and 5 out of 15 HBV-infected people (group C, single assay) showed significant primary liver damages including chronic hepatitis, toxic hepatitis, liver cirrhosis and hepatocellular carcinoma. In 5 cases (group B), one of which was type B liver cirrhosis, HBsAg became negative and HBsAb appeared during the follow-up period (up to 33 months). Among confirmed HBV carriers, HBsAg and HBV core antigen were most frequently found in the liver of cirrhotic cases with and without hepatocellular carcinoma (5 of 6), whereas these were rarely detected in those with non-specific changes or slight hepatitic activity (1 of 7). All 5 cases in group B were negative for histological HBV-related antigens and the findings in group C were variously interpreted. Post-mortem cases of the aged HBV carriers who survived their mean life expectancy represent an important population in which to study the natural history of HBV carriers.

UI MeSH Term Description Entries
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008107 Liver Diseases Pathological processes of the LIVER. Liver Dysfunction,Disease, Liver,Diseases, Liver,Dysfunction, Liver,Dysfunctions, Liver,Liver Disease,Liver Dysfunctions
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002353 Carrier State The condition of harboring an infective organism without manifesting symptoms of infection. The organism must be readily transmissible to another susceptible host. Asymptomatic Carrier State,Asymptomatic Infection Carrier,Inapparent Infection Carrier,Presymptomatic Carrier State,Presymptomatic Infection Carrier,Super-spreader Carrier,Superspreader Carrier,Asymptomatic Carrier States,Asymptomatic Infection Carriers,Carrier State, Asymptomatic,Carrier State, Presymptomatic,Carrier States,Carrier, Super-spreader,Carrier, Superspreader,Carriers, Super-spreader,Carriers, Superspreader,Inapparent Infection Carriers,Infection Carrier, Asymptomatic,Infection Carrier, Inapparent,Infection Carrier, Presymptomatic,Presymptomatic Carrier States,Presymptomatic Infection Carriers,Super spreader Carrier,Super-spreader Carriers,Superspreader Carriers
D005260 Female Females
D006509 Hepatitis B INFLAMMATION of the LIVER in humans caused by a member of the ORTHOHEPADNAVIRUS genus, HEPATITIS B VIRUS. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact. Hepatitis B Virus Infection
D006514 Hepatitis B Surface Antigens Those hepatitis B antigens found on the surface of the Dane particle and on the 20 nm spherical and tubular particles. Several subspecificities of the surface antigen are known. These were formerly called the Australia antigen. Australia Antigen,HBsAg,Hepatitis B Surface Antigen,Antigen, Australia
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

H Sugimura, and T Fukazawa, and M Saitoh, and K Nakamura, and H Shimada, and K Ohtsubo
January 1976, Transactions of the Royal Society of Tropical Medicine and Hygiene,
H Sugimura, and T Fukazawa, and M Saitoh, and K Nakamura, and H Shimada, and K Ohtsubo
January 2002, West African journal of medicine,
H Sugimura, and T Fukazawa, and M Saitoh, and K Nakamura, and H Shimada, and K Ohtsubo
October 1991, The Tokai journal of experimental and clinical medicine,
H Sugimura, and T Fukazawa, and M Saitoh, and K Nakamura, and H Shimada, and K Ohtsubo
January 2010, West African journal of medicine,
H Sugimura, and T Fukazawa, and M Saitoh, and K Nakamura, and H Shimada, and K Ohtsubo
January 1985, Acta paediatrica Scandinavica,
H Sugimura, and T Fukazawa, and M Saitoh, and K Nakamura, and H Shimada, and K Ohtsubo
December 1982, Lancet (London, England),
H Sugimura, and T Fukazawa, and M Saitoh, and K Nakamura, and H Shimada, and K Ohtsubo
March 1997, JPMA. The Journal of the Pakistan Medical Association,
H Sugimura, and T Fukazawa, and M Saitoh, and K Nakamura, and H Shimada, and K Ohtsubo
January 1990, Nephron,
H Sugimura, and T Fukazawa, and M Saitoh, and K Nakamura, and H Shimada, and K Ohtsubo
November 2016, Nephrology (Carlton, Vic.),
H Sugimura, and T Fukazawa, and M Saitoh, and K Nakamura, and H Shimada, and K Ohtsubo
May 1996, The Central African journal of medicine,
Copied contents to your clipboard!